Do you have the same question? Follow this Question
Nov 19, 2025 - 12:07 PM
We’ve provided several answers to questions related to Leqembi (Lecanemab) , see some other helpful Q&A related to this product.
Question: What approvals has this medication received?
Answer: The medication received Accelerated Approval from the US FDA in January 2023 and Traditional Approval in July 2023. FDA approval means the medication has been rigorously evaluated for safety and effectiveness, increasing patient confidence.
Question: What is the ATC code for this medication?
Answer: The ATC code is N06DX06. The Anatomical Therapeutic Chemical (ATC) classification system is used to categorize drugs, which helps in tracking usage and ensuring appropriate treatment choices.
Question: What is the bioavailability of this medication?
Answer: The bioavailability is 100% when administered intravenously (IV). Bioavailability refers to how much of the medication reaches the bloodstream, and 100% means the entire dose is available to act in the body, which is important for predictable treatment outcomes.
